Showing results (331-340 of 362) with videos related to
Sort By:
Pageof 37
Chemico-Biological Interactions|November 26, 2008
Pre-clinical antitumour evaluation of Biphosphinic Palladacycle Complex in human leukaemia cellsCarlos R Oliveira, Christiano M V Barbosa, Fábio D Nascimento, et al.Free Radical Biology & Medicine|February 19, 2013
17β-Estradiol and steady-state concentrations of H2O2: antiapoptotic effect in endometrial cells from patients with endometriosisSheila S Andrade, Aline de C Azevedo, Izabel C G Monasterio, et al.Brain Pathology (Zurich, Switzerland)|November 30, 2022
Leigh syndrome is the main clinical characteristic of PTCD3 deficiencyGerard Muñoz-Pujol, Juan D Ortigoza-Escobar, Abraham J Paredes-Fuentes, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|April 1, 2021
Artemether and lumefantrine dissolving microneedle patches with improved pharmacokinetic performance and antimalarial efficacy in mice infected with Plasmodium yoeliiFabiana Volpe-Zanutto, Letícia Tiburcio Ferreira, Andi Dian Permana, et al.ACS Infectious Diseases|April 27, 2023
In Vivo Antileishmanial Effect of 3,5-Diaryl-isoxazole Analogues Based on Veraguensin, Grandisin, and Machilin G: A Glance at a Preclinical StudyAmarith R das Neves, Diego B Carvalho, Fernanda Silva, et al.Scientific Reports|July 12, 2020
PPARβ/δ-dependent MSC metabolism determines their immunoregulatory propertiesR A Contreras-Lopez, R Elizondo-Vega, M J Torres, et al.JCI Insight|September 29, 2020
KrasP34R and KrasT58I mutations induce distinct RASopathy phenotypes in miceJasmine C Wong, Pedro A Perez-Mancera, Tannie Q Huang, et al.Nature|September 4, 2009
Response and resistance to MEK inhibition in leukaemias initiated by hyperactive RasJennifer O Lauchle, Doris Kim, Doan T Le, et al.Natural Product Research|October 17, 2014
Essential oil from the leaves of Xylopia langsdorfiana (Annonaceae) as a possible spasmolytic agentAna Carolina de C Correia, Tamyris F Ferreira, Italo Rossi R Martins, et al.Frontiers in Immunology|May 4, 2026
SCID newborn screening: seven-year performance and outcomes including T-cell lymphopenia in Catalonia (Spain)Ana Argudo-Ramírez, Andrea Martín-Nalda, Javier Laguna, et al.Pageof 37